共 50 条
- [42] Re: Validation of the 2015 Prostate Cancer Grade Groups for Predicting Long-Term Oncologic Outcomes in a Shared Equal-Access Health System Editorial Comment JOURNAL OF UROLOGY, 2018, 200 (03): : 499 - 499
- [44] COMPARISON OF CELL CYCLE PROGRESSION (CCP) SCORE TO TWO IHC MARKERS (PTEN AND KI-67) FOR PREDICTING OUTCOME IN PROSTATE CANCER AFTER RADICAL PROSTATECTOMY. JOURNAL OF UROLOGY, 2018, 199 (04): : E453 - E454
- [45] Re: Perineural Invasion Predicts Increased Recurrence, Metastasis, and Death From Prostate Cancer Following Treatment With Dose-Escalated Radiation Therapy Editorial Comment JOURNAL OF UROLOGY, 2012, 187 (03): : 911 - 911
- [46] PROGNOSTIC UTILITY OF BIOPSY-DERIVED CELL CYCLE PROGRESSION SCORE IN PATIENTS WITH NCCN LOW-RISK PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY: IMPLICATIONS FOR TREATMENT GUIDANCE JOURNAL OF UROLOGY, 2017, 197 (04): : E343 - E343
- [47] Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy Editorial Comment Reply by Authors JOURNAL OF UROLOGY, 2022, 208 (06): : 1192 - 1210
- [50] Re: Predicting the 10-Year Risk of Death from Other Causes in Men with Localized Prostate Cancer Using Patient-Reported Factors: Development of a Tool Comment JOURNAL OF UROLOGY, 2021, 205 (06): : 1823 - 1823